Literature DB >> 24455477

Lysosomal storage diseases: heterogeneous group of disorders.

David A Wenger1, Paola Luzi1, Mohammad A Rafi1.   

Abstract

The name of lysosomal storage diseases stems from the fact that in this category of disorders specific undegraded materials are stored in the lysosomes. This is usually caused by a lysosomal enzyme deficiency and leads to a cascade of pathological outcomes. Apart from deficiency of lysosomal enzymes, lysosomal storage diseases also include deficiencies in proteins necessary for enzyme functioning, proteins needed for post-translational modification of these enzymes and proteins required for export of certain compounds from the lysosomes.

Entities:  

Keywords:  LSDs; Lysosomal storage diseases; Psychosine; SAPs; Saposins; Sphingolipid activator proteins

Year:  2013        PMID: 24455477      PMCID: PMC3892733          DOI: 10.5681/bi.2013.029

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  12 in total

Review 1.  Saposin proteins: structure, function, and role in human lysosomal storage disorders.

Authors:  J S O'Brien; Y Kishimoto
Journal:  FASEB J       Date:  1991-03-01       Impact factor: 5.191

Review 2.  Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis.

Authors:  C G Schuette; B Pierstorff; S Huettler; K Sandhoff
Journal:  Glycobiology       Date:  2001-06       Impact factor: 4.313

3.  Gene and stem cell therapy: alone or in combination?

Authors:  Mohammad A Rafi
Journal:  Bioimpacts       Date:  2011-12-09

4.  Saposin A: second cerebrosidase activator protein.

Authors:  S Morimoto; B M Martin; Y Yamamoto; K A Kretz; J S O'Brien; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency.

Authors:  M A Rafi; G de Gala; X L Zhang; D A Wenger
Journal:  Somat Cell Mol Genet       Date:  1993-01

Review 6.  Globoid cell leukodystrophy (Krabbe's disease): update.

Authors:  Kunihiko Suzuki
Journal:  J Child Neurol       Date:  2003-09       Impact factor: 1.987

7.  Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.

Authors:  Junko Matsuda; Makiko Kido; Keiko Tadano-Aritomi; Ineo Ishizuka; Kumiko Tominaga; Kazunori Toida; Eiji Takeda; Kunihiko Suzuki; Yasuhiro Kuroda
Journal:  Hum Mol Genet       Date:  2004-09-02       Impact factor: 6.150

8.  Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation.

Authors:  Mariam Zaka; David A Wenger
Journal:  Neurosci Lett       Date:  2004-04-01       Impact factor: 3.046

Review 9.  Lysosomal storage disorders: diagnostic dilemmas and prospects for therapy.

Authors:  David A Wenger; Stephanie Coppola; Shu-Ling Liu
Journal:  Genet Med       Date:  2002 Nov-Dec       Impact factor: 8.822

Review 10.  The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.

Authors:  Frances M Platt; Barry Boland; Aarnoud C van der Spoel
Journal:  J Cell Biol       Date:  2012-11-26       Impact factor: 10.539

View more
  2 in total

1.  Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.

Authors:  Christopher J Folts; Nicole Scott-Hewitt; Christoph Pröschel; Margot Mayer-Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2016-12-15       Impact factor: 8.029

2.  Enzyme replacement therapies: what is the best option?

Authors:  Azam Safary; Mostafa Akbarzadeh Khiavi; Rahimeh Mousavi; Jaleh Barar; Mohammad A Rafi
Journal:  Bioimpacts       Date:  2018-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.